These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15937208

  • 21. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H, Ichimiya S, Kanashiro M, Aoyama T, Ogawa Y, Murakami R, Amano T, Naruse K, Matsubara T, Murohara T.
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [Abstract] [Full Text] [Related]

  • 22. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 23. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 01; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 24. The incidence, treatment strategies and outcomes of acute coronary syndromes in the "reperfusion network" of different hospital types in the Czech Republic: results of the Czech evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.
    Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M, CZECH investigators.
    Int J Cardiol; 2007 Jul 10; 119(2):212-9. PubMed ID: 17442424
    [Abstract] [Full Text] [Related]

  • 25. Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database.
    Hiratzka LF, Eagle KA, Liang L, Fonarow GC, LaBresh KA, Peterson ED, Get With the Guidelines Steering Committee.
    Circulation; 2007 Sep 11; 116(11 Suppl):I207-12. PubMed ID: 17846305
    [Abstract] [Full Text] [Related]

  • 26. [Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].
    Cournot M, Cambou JP, Quentzel S, Danchin N.
    Ann Cardiol Angeiol (Paris); 2005 Dec 11; 54 Suppl 1():S17-23. PubMed ID: 16411647
    [Abstract] [Full Text] [Related]

  • 27. Association of aspirin dosage to clinical outcomes after percutaneous coronary intervention: observations from the Ottawa Heart Institute PCI Registry.
    So D, Cook EF, Le May M, Glover C, Williams W, Ha A, Davies R, Froeschl M, Marquis JF, O'Brien E, Labinaz M.
    J Invasive Cardiol; 2009 Mar 11; 21(3):121-7. PubMed ID: 19258643
    [Abstract] [Full Text] [Related]

  • 28. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 11; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 29. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P, Portuguese Registry on Acute Coronary Syndromes.
    Circulation; 2006 Jul 04; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [Abstract] [Full Text] [Related]

  • 30. [Influence of percutaneous coronary intervention in non ST-elevation acute coronary syndromes on prescription of secondary prevention medications. Data from the S-Témoin Registry].
    Danchin N, Thébaut JF, Diévart F, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Ann Cardiol Angeiol (Paris); 2007 Jan 04; 56(1):30-5. PubMed ID: 17343036
    [Abstract] [Full Text] [Related]

  • 31. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.
    Blackledge HM, Squire IB.
    Heart; 2009 Feb 04; 95(4):304-11. PubMed ID: 19001000
    [Abstract] [Full Text] [Related]

  • 32. [Long-term treatment with statins in patients with ischemic heart disease after coronary angioplasty].
    Skulec R, Linhart A, Hnátek T, Spundová H, Mrázek V, Bĕlohlávek J, Holm F, Aschermann M.
    Vnitr Lek; 2003 Apr 04; 49(4):285-90. PubMed ID: 12793051
    [Abstract] [Full Text] [Related]

  • 33. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec 04; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 34. [Medical therapy in revascularized coronary artery disease patients].
    Liu XH, DU X, Kang JP, Lü Q, Zhang Q, Lü SZ, Chen F, Ma CS.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):236-9. PubMed ID: 18361833
    [Abstract] [Full Text] [Related]

  • 35. Secondary prevention of coronary heart disease in the elderly.
    Dornbrook-Lavender KA, Roth MT, Pieper JA.
    Ann Pharmacother; 2003 Dec 22; 37(12):1867-76. PubMed ID: 14632542
    [Abstract] [Full Text] [Related]

  • 36. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 37. Do practice gaps exist in evidence-based medication prescription at hospital discharge in patients undergoing coronary artery bypass surgery & coronary angioplasty?
    Pereira P, Kapoor A, Sinha A, Agarwal SK, Pande S, Khanna R, Srivastava N, Kumar S, Garg N, Tewari S, Goel P.
    Indian J Med Res; 2017 Dec 23; 146(6):722-729. PubMed ID: 29664030
    [Abstract] [Full Text] [Related]

  • 38. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC, Gu L, Cantley LK, Sheedy DJ, Cohen SJ.
    Am Heart J; 2003 Dec 23; 146(6):1045-51. PubMed ID: 14660997
    [Abstract] [Full Text] [Related]

  • 39. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ, Prince SL, Herbert M, Brown PP, Katz M, Palmer G, Edgerton JR, Eichhorn E, Magee MJ, Dewey TM.
    Ann Thorac Surg; 2008 Aug 23; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [Abstract] [Full Text] [Related]

  • 40. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N, Diévart F, Thébaut JF, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Int J Cardiol; 2009 Mar 20; 133(1):32-40. PubMed ID: 18375000
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.